Ashraf Hanna

This profile gathers the share dealings of Ashraf Hanna in Nexvet Biopharma plc. The record holds 16 filings, for trades running from 18 May 2015 to 31 July 2017.

On the market, this insider has only ever bought: 1 purchase, €4,413 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 13 option exercises.

Most recently, on 2 August 2017, the filings show a transaction worth €91k in Nexvet Biopharma plc. The clock since the last published purchase (3 March 2016) now reads 3,903 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.